LL-VNS modulated inflammatory cytokine levels (TNF-α, IL-6), increased STAT3 expression, and reduced NF-κB expression, demonstrating that LL-VNS modulates AF vulnerability through the α7nAChR-mediated cholinergic anti-inflammatory pathway (CAP). The gene discussed is TNF; the disease is atrial fibrillation.